162 related articles for article (PubMed ID: 20633696)
21. Phenotypic characterization of telomerase-immortalized primary non-malignant and malignant tumor-derived human prostate epithelial cell lines.
Gu Y; Li H; Miki J; Kim KH; Furusato B; Sesterhenn IA; Chu WS; McLeod DG; Srivastava S; Ewing CM; Isaacs WB; Rhim JS
Exp Cell Res; 2006 Apr; 312(6):831-43. PubMed ID: 16413016
[TBL] [Abstract][Full Text] [Related]
22. Markers of prostate region-specific epithelial identity define anatomical locations in the mouse prostate that are molecularly similar to human prostate cancers.
Thielen JL; Volzing KG; Collier LS; Green LE; Largaespada DA; Marker PC
Differentiation; 2007 Jan; 75(1):49-61. PubMed ID: 17244021
[TBL] [Abstract][Full Text] [Related]
23. Phosphorylation status of Fas-associated death domain-containing protein (FADD) is associated with prostate cancer progression.
Shimada K; Matsuyoshi S; Nakamura M; Ishida E; Konishi N
J Pathol; 2005 Aug; 206(4):423-32. PubMed ID: 15906275
[TBL] [Abstract][Full Text] [Related]
24. Tissue-specific consequences of cyclin D1 overexpression in prostate cancer progression.
He Y; Franco OE; Jiang M; Williams K; Love HD; Coleman IM; Nelson PS; Hayward SW
Cancer Res; 2007 Sep; 67(17):8188-97. PubMed ID: 17804732
[TBL] [Abstract][Full Text] [Related]
25. Expression of RIZ1 protein (Retinoblastoma-interacting zinc-finger protein 1) in prostate cancer epithelial cells changes with cancer grade progression and is modulated in vitro by DHT and E2.
Rossi V; Staibano S; Abbondanza C; Pasquali D; De Rosa C; Mascolo M; Bellastella G; Visconti D; De Bellis A; Moncharmont B; De Rosa G; Puca GA; Bellastella A; Sinisi AA
J Cell Physiol; 2009 Dec; 221(3):771-7. PubMed ID: 19746436
[TBL] [Abstract][Full Text] [Related]
26. Androgen receptor levels in prostate cancer epithelial and peritumoral stromal cells identify non-organ confined disease.
Ricciardelli C; Choong CS; Buchanan G; Vivekanandan S; Neufing P; Stahl J; Marshall VR; Horsfall DJ; Tilley WD
Prostate; 2005 Apr; 63(1):19-28. PubMed ID: 15378523
[TBL] [Abstract][Full Text] [Related]
27. A novel biomarker for staging human prostate adenocarcinoma: overexpression of matriptase with concomitant loss of its inhibitor, hepatocyte growth factor activator inhibitor-1.
Saleem M; Adhami VM; Zhong W; Longley BJ; Lin CY; Dickson RB; Reagan-Shaw S; Jarrard DF; Mukhtar H
Cancer Epidemiol Biomarkers Prev; 2006 Feb; 15(2):217-27. PubMed ID: 16492908
[TBL] [Abstract][Full Text] [Related]
28. Stemness markers characterize IGR-CaP1, a new cell line derived from primary epithelial prostate cancer.
Chauchereau A; Al Nakouzi N; Gaudin C; Le Moulec S; Compagno D; Auger N; Bénard J; Opolon P; Rozet F; Validire P; Fromont G; Fizazi K
Exp Cell Res; 2011 Feb; 317(3):262-75. PubMed ID: 20974126
[TBL] [Abstract][Full Text] [Related]
29. Reduced growth and integrin expression of prostate cells cultured with lycopene, vitamin E and fish oil in vitro.
Bureyko T; Hurdle H; Metcalfe JB; Clandinin MT; Mazurak VC
Br J Nutr; 2009 Apr; 101(7):990-7. PubMed ID: 18718045
[TBL] [Abstract][Full Text] [Related]
30. Metabolomics by proton nuclear magnetic resonance spectroscopy of the response to chloroethylnitrosourea reveals drug efficacy and tumor adaptive metabolic pathways.
Morvan D; Demidem A
Cancer Res; 2007 Mar; 67(5):2150-9. PubMed ID: 17332345
[TBL] [Abstract][Full Text] [Related]
31. Cell death in irradiated prostate epithelial cells: role of apoptotic and clonogenic cell kill.
Bromfield GP; Meng A; Warde P; Bristow RG
Prostate Cancer Prostatic Dis; 2003; 6(1):73-85. PubMed ID: 12664070
[TBL] [Abstract][Full Text] [Related]
32. The toll-like receptor pathway: a novel mechanism of infection-induced carcinogenesis of prostate epithelial cells.
Kundu SD; Lee C; Billips BK; Habermacher GM; Zhang Q; Liu V; Wong LY; Klumpp DJ; Thumbikat P
Prostate; 2008 Feb; 68(2):223-9. PubMed ID: 18092352
[TBL] [Abstract][Full Text] [Related]
33. Ubiquitous mitochondrial creatine kinase is overexpressed in the conditioned medium and the extract of LNCaP lineaged androgen independent cell lines and facilitates prostate cancer progression.
Pang B; Zhang H; Wang J; Chen WZ; Li SH; Shi QG; Liang RX; Xie BX; Wu RQ; Qian XL; Yu L; Li QM; Huang CF; Zhou JG
Prostate; 2009 Aug; 69(11):1176-87. PubMed ID: 19415690
[TBL] [Abstract][Full Text] [Related]
34. Statistically integrated metabonomic-proteomic studies on a human prostate cancer xenograft model in mice.
Rantalainen M; Cloarec O; Beckonert O; Wilson ID; Jackson D; Tonge R; Rowlinson R; Rayner S; Nickson J; Wilkinson RW; Mills JD; Trygg J; Nicholson JK; Holmes E
J Proteome Res; 2006 Oct; 5(10):2642-55. PubMed ID: 17022635
[TBL] [Abstract][Full Text] [Related]
35. Expression of core 2 beta1,6-N-acetylglucosaminyltransferase facilitates prostate cancer progression.
Hagisawa S; Ohyama C; Takahashi T; Endoh M; Moriya T; Nakayama J; Arai Y; Fukuda M
Glycobiology; 2005 Oct; 15(10):1016-24. PubMed ID: 15932919
[TBL] [Abstract][Full Text] [Related]
36. Metabolic response of the CWR22 prostate tumor xenograft after 20 Gy of radiation studied by 1H spectroscopic imaging.
Dyke JP; Zakian KL; Spees WM; Matei C; Chen Y; Mao X; Shungu DC; Koutcher JA
Clin Cancer Res; 2003 Oct; 9(12):4529-36. PubMed ID: 14555527
[TBL] [Abstract][Full Text] [Related]
37. Hypoxia-induced metabolic shifts in cancer cells: moving beyond the Warburg effect.
Weljie AM; Jirik FR
Int J Biochem Cell Biol; 2011 Jul; 43(7):981-9. PubMed ID: 20797448
[TBL] [Abstract][Full Text] [Related]
38. MRL/lpr mice have alterations in brain metabolism as shown with [1H-13C] NMR spectroscopy.
Alexander JJ; Zwingmann C; Quigg R
Neurochem Int; 2005 Jul; 47(1-2):143-51. PubMed ID: 15893408
[TBL] [Abstract][Full Text] [Related]
39. Heat shock protein expression independently predicts clinical outcome in prostate cancer.
Cornford PA; Dodson AR; Parsons KF; Desmond AD; Woolfenden A; Fordham M; Neoptolemos JP; Ke Y; Foster CS
Cancer Res; 2000 Dec; 60(24):7099-105. PubMed ID: 11156417
[TBL] [Abstract][Full Text] [Related]
40. Elevated levels of versican but not decorin predict disease progression in early-stage prostate cancer.
Ricciardelli C; Mayne K; Sykes PJ; Raymond WA; McCaul K; Marshall VR; Horsfall DJ
Clin Cancer Res; 1998 Apr; 4(4):963-71. PubMed ID: 9563891
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
